Dengue shock syndrome

GPTKB entity

Statements (54)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:bfsLayer 5
gptkbp:bfsParent gptkb:Dengue_fever
gptkbp:associated_with gptkb:Dengue_hemorrhagic_fever
gptkb:Dengue_fever
gptkbp:caused_by gptkb:healthcare_organization
gptkbp:clinical_trial requires early intervention
requires monitoring
requires fluid resuscitation
requires supportive care
gptkbp:complications shock
organ failure
hemorrhagic manifestations
gptkbp:distribution gptkb:Caribbean
gptkb:Latin_America
gptkb:Southeast_Asia
gptkb:Pacific_Islands
gptkbp:end_of_life higher in severe cases
1% to 5% with treatment
up to 20% without treatment
gptkbp:first_described_by in the 1960s
gptkbp:genetic_diversity gptkb:DENV-1
gptkb:DENV-2
gptkb:DENV-3
gptkb:DENV-4
gptkbp:healthcare in urban areas
in endemic regions
in tropical climates
in high-density populations
in low-resource settings
https://www.w3.org/2000/01/rdf-schema#label Dengue shock syndrome
gptkbp:is_protected_by vaccination
mosquito control
gptkbp:research_focus treatment protocols
vaccine development
vector control strategies
gptkbp:risk_factor previous dengue infection
age under 12
gptkbp:social_responsibility tropical and subtropical regions
seasonal outbreaks
clinical evaluation
laboratory tests
linked to climate change
linked to population movement
linked to urbanization
gptkbp:symptoms fatigue
restlessness
bleeding gums
severe abdominal pain
persistent vomiting
rapid breathing
gptkbp:transmission gptkb:Aedes_mosquitoes
gptkbp:treatment intravenous fluids
blood transfusion